Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richa Giri

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Diabetes & Metabolic Syndrome|June 29, 2021
Cognitive impairment in type 2 diabetes and its impact on daily living and self-care: A case - Control study in Kanpur, North IndiaShivendra Verma, Saurabh Agarwal, Sorang Tashok, et al.
Plos One|May 27, 2026
PCR-based detection and phylogenetic analysis of Candidatus Liberibacter asiaticus in citrus orchards across NepalRicha Giri, Bal Kumari Oliya, Siddartha Gautam, et al.
Frontiers in Immunology|December 26, 2022
Protective role of engineered extracellular vesicles loaded quercetin nanoparticles as anti-viral therapy against SARS-CoV-2 infection: A prospective reviewAlok Raghav, Richa Giri, Saurabh Agarwal, et al.
Frontiers in Endocrinology|November 17, 2022
New horizons of biomaterials in treatment of nerve damage in diabetes mellitus: A translational prospective reviewAlok Raghav, Manish Singh, Goo-Bo Jeong, et al.
Frontiers in Molecular Neuroscience|December 12, 2022
Extracellular vesicles in neurodegenerative diseases: A systematic reviewAlok Raghav, Manish Singh, Goo-Bo Jeong, et al.
Frontiers in Microbiology|October 28, 2021
Newer Horizon of Mesenchymal Stem Cell-Based Therapy in the Management of SARS-CoV-2-Associated Mucormycosis: A Safe Hope for Future MedicineAlok Raghav, Syed Ghazanfar Ali, Goo-Bo Jeong, et al.
Cureus|March 20, 2026
A Randomized, Multicenter Study Evaluating the Efficacy, Safety and Tolerability of Dapagliflozin + Gliclazide Fixed Dose Combination Over Dapagliflozin Monotherapy in Type 2 Diabetes Mellitus Patients Inadequately Controlled on Metformin MonotherapySuhas G Erande, Amar Raykantiwar, Vivek Shejole, et al.
Advances in Therapy|May 31, 2023
Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual CombinationsRakesh K Sahay, Richa Giri, Jayashree V Shembalkar, et al.
Diabetes, Obesity & Metabolism|July 6, 2026
Semaglutide Injection Once-Weekly for Weight Management in Adults: Results From A Randomized Phase III, Active-Controlled StudyUnnikrishnan Ambika Gopalakrishnan, Ameya Joshi, Harish Kumar, et al.
Cureus|March 26, 2026
Comparative Efficacy and Safety of Once-Weekly Semaglutide Formulations in Indian Adults With Obesity: A Phase III, Randomized Non-inferiority Active-Controlled Study (Size Plus Study)Nitin Kapoor, Sanjay Kalra, Arindam Naskar, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Diabetes & Metabolic Syndrome|June 29, 2021
Cognitive impairment in type 2 diabetes and its impact on daily living and self-care: A case - Control study in Kanpur, North IndiaShivendra Verma, Saurabh Agarwal, Sorang Tashok, et al.
Plos One|May 27, 2026
PCR-based detection and phylogenetic analysis of Candidatus Liberibacter asiaticus in citrus orchards across NepalRicha Giri, Bal Kumari Oliya, Siddartha Gautam, et al.
Frontiers in Immunology|December 26, 2022
Protective role of engineered extracellular vesicles loaded quercetin nanoparticles as anti-viral therapy against SARS-CoV-2 infection: A prospective reviewAlok Raghav, Richa Giri, Saurabh Agarwal, et al.
Frontiers in Endocrinology|November 17, 2022
New horizons of biomaterials in treatment of nerve damage in diabetes mellitus: A translational prospective reviewAlok Raghav, Manish Singh, Goo-Bo Jeong, et al.
Frontiers in Molecular Neuroscience|December 12, 2022
Extracellular vesicles in neurodegenerative diseases: A systematic reviewAlok Raghav, Manish Singh, Goo-Bo Jeong, et al.
Frontiers in Microbiology|October 28, 2021
Newer Horizon of Mesenchymal Stem Cell-Based Therapy in the Management of SARS-CoV-2-Associated Mucormycosis: A Safe Hope for Future MedicineAlok Raghav, Syed Ghazanfar Ali, Goo-Bo Jeong, et al.
Cureus|March 20, 2026
A Randomized, Multicenter Study Evaluating the Efficacy, Safety and Tolerability of Dapagliflozin + Gliclazide Fixed Dose Combination Over Dapagliflozin Monotherapy in Type 2 Diabetes Mellitus Patients Inadequately Controlled on Metformin MonotherapySuhas G Erande, Amar Raykantiwar, Vivek Shejole, et al.
Advances in Therapy|May 31, 2023
Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual CombinationsRakesh K Sahay, Richa Giri, Jayashree V Shembalkar, et al.
Diabetes, Obesity & Metabolism|July 6, 2026
Semaglutide Injection Once-Weekly for Weight Management in Adults: Results From A Randomized Phase III, Active-Controlled StudyUnnikrishnan Ambika Gopalakrishnan, Ameya Joshi, Harish Kumar, et al.
Cureus|March 26, 2026
Comparative Efficacy and Safety of Once-Weekly Semaglutide Formulations in Indian Adults With Obesity: A Phase III, Randomized Non-inferiority Active-Controlled Study (Size Plus Study)Nitin Kapoor, Sanjay Kalra, Arindam Naskar, et al.
Pageof 2